Bioventus SG&A Expense (TTM) Analysis

Bioventus Inc (BVS)

6.06 +0.23 (+3.95%) USD | NASDAQ | Jul 08, 16:00

6.06 0.00 (0.00%) After-Hours: 19:13

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	301.43M
December 31, 2023	303.88M
September 30, 2023	302.96M
June 30, 2023	312.09M
March 31, 2023	326.87M
December 31, 2022	332.13M
September 30, 2022	335.58M
June 30, 2022	326.26M
March 31, 2022	305.69M

Date	Value
December 31, 2021	254.25M
September 30, 2021	235.35M
June 30, 2021	216.00M
March 31, 2021	187.49M
December 31, 2020	193.08M
September 30, 2020	185.56M
June 30, 2020	175.45M
March 31, 2020	172.18M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

172.18M

Minimum

Mar 2020

335.58M

Maximum

Sep 2022

262.72M

Average

301.43M

Median

Mar 2024

SG&A Expense (TTM) Benchmarks